Palliative chemotherapy.
Ellison NM.
Am J Hosp Palliat Care. 1998 Mar-Apr;15(2):93-103. doi: 10.1177/104990919801500208.
Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer.
Janmaat VT, Steyerberg EW, van der Gaast A, Mathijssen RH, Bruno MJ, Peppelenbosch MP, Kuipers EJ, Spaander MC.
Cochrane Database Syst Rev. 2017 Nov 28;11(11):CD004063. doi: 10.1002/14651858.CD004063.pub4.
[Palliative chemotherapy].
Osieka R.
Zentralbl Chir. 1998;123(6):714-21.
Challenges and Advancements in Palliative Chemotherapy for Ampullary Adenocarcinoma.
Kim EJ.
Gut Liver. 2024 Jul 15;18(4):560-561. doi: 10.5009/gnl240283.
Palliative chemotherapy for malignant ascites secondary to ovarian cancer.
Malayev Y, Levene R, Gonzalez F.
Am J Hosp Palliat Care. 2012 Nov;29(7):515-21. doi: 10.1177/1049909111434044. Epub 2012 Feb 23.
Chemotherapy versus palliative care in non-small cell lung cancer.
Nicum S, Cullen MH.
Anticancer Drugs. 2000 Sep;11(8):603-7. doi: 10.1097/00001813-200009000-00001.
Palliative chemotherapy for recurrent and metastatic esophageal cancer.
Grünberger B, Raderer M, Schmidinger M, Hejna M.
Anticancer Res. 2007 Jul-Aug;27(4C):2705-14.
Provision of Palliative Combined Pembrolizumab-Chemotherapy in Head and Neck Cancer in England: Time for a Review of the Evidence.
Kelly C, Barnett G, Iqbal MS.
Clin Oncol (R Coll Radiol). 2024 Sep;36(9):534-536. doi: 10.1016/j.clon.2024.05.007. Epub 2024 May 15.
Palliative chemotherapy for patients with synchronous metastases of small-bowel adenocarcinoma: A reflection of daily practice.
Legué LM, Bernards N, Lemmens VE, de Hingh IH, Creemers GJ, van Erning FN.
United European Gastroenterol J. 2019 Dec;7(10):1380-1388. doi: 10.1177/2050640619858211. Epub 2019 Jun 14.
Palliative chemotherapy for non-small cell lung cancer.
Adelstein DJ.
Semin Oncol. 1995 Apr;22(2 Suppl 3):35-9.
